The maker of mind recreation app Lumosity has agreed to pay $2 million to settle prices introduced by means of the Federal change commission, which alleged it deceived customers in regards to the product’s mind-coaching advantages.

The FTC said Tuesday that Lumosity made “unfounded claims” that its games might assist customers do better at work and school and assist cut back the results of stipulations including Alzheimer’s, consideration deficit hyperactivity disorder, and stressful brain injury.

“Lumosity preyed on consumers’ fears about age-associated cognitive decline, suggesting their games might stave off memory loss, dementia, and even Alzheimer’s illness,” said Jessica rich, the director of the FTC’s Bureau of client safety, in a commentary. “however Lumosity merely didn’t have the science to back up its advertisements.”

The San Francisco-primarily based firm, founded in 2005, says it has more than 70 million registered customers all over the world, who’re in a position to play its video games on the net and on apps for iPhone and Android units. Lumosity mentioned in a remark Tuesday that it intends to proceed offering its merchandise to users.

“Neither the action nor the contract pertains to the rigor of our research or the quality of the merchandise—it is a reflection of marketing language that has been discontinued,” the corporate stated. “Our center of attention as an organization has not and will not change: We stay committed to moving the science of cognitive coaching forward and contributing meaningfully to the sphere’s community and body of research.”

the company additionally allegedly failed to notify buyers that some testimonials on its website “had been solicited through contests that promised significant prizes, together with a free iPad, a lifetime Lumosity subscription, and a spherical-shuttle to San Francisco,” in line with the FTC.

under the terms of the agreement, the company agreed to inform clients who signed up for auto-renewal subscriptions between Jan. 1, 2009 and Dec. 31, 2014, concerning the FTC’s allegations and provides them the opportunity to cancel their subscriptions. the corporate also agreed to not make additional scientific claims without “competent and reliable scientific evidence.”

Lumosity, which supplies brain researchers free get right of entry to to its brain-coaching instruments through its Human Cognition challenge, says it intends to continue to reinforce research into the effectiveness of its product.

In a observation to fast company, a Lumosity spokeswoman said:

The contemporary peer-reviewed medical check printed in the journal PLOS One is a huge, randomized, lively-managed trial of our cognitive coaching application. The find out about suggested that individuals who educated with Lumosity for 10 weeks more desirable on an combination evaluate of cognition. Going forward, a key focal point of our ongoing research is to build on these research to higher take note how coaching-driven enhancements on assessments of cognition translate to efficiency in participants’ everyday lives.